Kristen Baldwin
Chief People Officer
Replay available
Selecta Biosciences, Inc. (SELB) Q2 2021 Earnings Call
Selecta Biosciences, Inc. (NASDAQ: SELB) Q2 2021 earnings conference call, held 2021-08-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Carsten Bruhn
President and Chief Executive Officer
Kristen Kluska
Analyst at Cantor Fitzgerald
Kai Kishimoto
Chief Scientific Officer
Peter Traber
Chief Medical Officer
Raju Prasad
Analyst at William Blair
John Newman
Analyst at Canaccord
Dan Clark
Analyst at Mizuho Securities
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cartesian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.293 Good morning, everyone, and welcome to the Selecta Biosciences second quarter 2021 00:00:05.293 -- 00:00:08.956 financial results and corporate update conference call. 00:00:08.956 -- 00:00:12.358 Currently, all participants are in a listen-only mode. 00:00:12.358 -- 00:00:17.582 This call is being webcast live on the investors and media section of Selecta's website 00:00:17.582 -- 00:00:19.922 at www.selectabio.com 00:00:21.985 -- 00:00:24.546 and is being recorded. 00:00:24.790 -- 00:00:29.593 For opening remarks, I would like to introduce Kristen Baldwin, Chief People Officer 00:00:29.593 -- 00:00:32.994 of Selecta. Please go ahead. 00:00:34.237 -- 00:00:38.220 Thank you and good morning. Welcome to our second quarter 2021 00:00:38.220 -- 00:00:41.222 financial results and corporate update conference call. 00:00:41.222 -- 00:00:46.025 The press release reporting our financial results is available in the investor and media 00:00:46.025 -- 00:00:50.547 section of Selecta's website, www.selectabio.com. 00:00:51.693 -- 00:00:57.156 And the quarterly report on Form 10-Q ended June 30th, 2021, 00:00:57.156 -- 00:01:00.618 which was filed today with the SEC. 00:01:00.618 -- 00:01:06.061 Joining me today are Karsten Bruhn, President and Chief Executive Officer, Peter Traber, 00:01:06.061 -- 00:01:08.742 Chief Medical Officer, and 00:01:08.742 -- 00:01:13.715 Kate, excuse me, Kai Kishimoto, Chief Scientific Officer. 00:01:13.715 -- 00:01:17.738 During today's call, we will be making certain forward-looking statements, including, 00:01:17.738 -- 00:01:23.101 without limitation, statements about the potential, safety, efficacy, and regulatory 00:01:23.101 -- 00:01:27.925 and clinical progress of our product candidates, financial projection...